Baird Upgrades MedAssets (MDAS) to Outperform, Price Target $25
Tweet Send to a Friend
Baird upgraded MedAssets (NASDAQ: MDAS) to an Outperform rating from its previous rating ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


